Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Expert Review of Anticancer Therapy|September 8, 2020
Gender discrepancies in bladder cancer: potential explanationsPravin Viswambaram, Dickon HayneUrology Case Reports|April 19, 2021
Adenocarcinoma of the urethra: A rare subtype of urethral cancerPravin Viswambaram, Oliver Oey, Nicole Swarbrick, et al.Folia Medica|July 20, 2022
Anterior pelvic exenteration and synchronous bilateral nephroureterectomy for BK polyoma virus induced urothelial carcinoma of the bladder: A case reportOliver Oey, Pravin Viswambaram, Andrew Moe, et al.Urology Case Reports|June 4, 2020
Multi-route antifungal administration in the management of urinary Candida glabrata bezoarPravin Viswambaram, Jeanie Misko, Matthew Rawlins, et al.Journal of Public Health Research|January 16, 2023
Analysis of the financial impact and efficiency of the One Stop Prostate Clinic: A same day prostate cancer diagnostic clinic in the Australian public health systemCynthia Hawks, Mohammed Al-Zubaidi, Pravin Viswambaram, et al.Asia-Pacific Journal of Clinical Oncology|November 10, 2022
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy databasePravin Viswambaram, Steve P McCombie, Cynthia Hawks, et al.European Journal of Cancer Care|July 26, 2021
Nurse-led telephone notification of a prostate cancer diagnosis: Prospective analysis of men's preferences for and experiences of a same-day assessment and diagnostic clinicCynthia Hawks, Pravin Viswambaram, Claire Cloney, et al.BJU International|April 2, 2022
Technetium-99 m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal massesPravin Viswambaram, Nicole Swarbrick, Alarick Picardo, et al.ANZ Journal of Surgery|March 3, 2023
Lymph node assessment technique matters in radical cystectomy for bladder cancerMatthew Chau, Ivan Thia, Pravin Viswambaram, et al.BMJ Open|April 16, 2022
89Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinomaMohammed Al-Zubaidi, Pravin Viswambaram, Steve McCombie, et al.Pageof 9